4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-056261
Chief Scientific Officer sold 11,685 shares at an average $36.98 ($432,054)
- Chief Scientific Officer acquired 11,685 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-13 | Exercise or conversion : show line 1 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-09-13 | Sale : show line 2 in the form | −2,995 | $37.39 | $111,983 | 70,260 | D |
| 2021-09-13 | Sale : show line 3 in the form | −900 | $37.89 | $34,101 | 69,360 | D |
| 2021-09-14 | Exercise or conversion : show line 4 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-09-14 | Sale : show line 5 in the form | −2,795 | $36.49 | $101,990 | 70,460 | D |
| 2021-09-14 | Sale : show line 6 in the form | −1,100 | $37.36 | $41,096 | 69,360 | D |
| 2021-09-15 | Exercise or conversion : show line 7 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-09-15 | Sale : show line 8 in the form | −2,995 | $36.52 | $109,377 | 70,260 | D |
| 2021-09-15 | Sale : show line 9 in the form | −900 | $37.23 | $33,507 | 69,360 | D |
| Open-market sales · 11,685 sh · avg $36.98 · $432,054 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-13 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −3,895 | 89,585 | D |
| 2021-09-14 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −3,895 | 85,690 | D |
| 2021-09-15 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −3,895 | 81,795 | D |
Loading xslF345X03/doc4.xml…